Related Experiment Videos
Azelaic acid: potential as a general antitumoural agent
1Division of Physiology, UMDS, St Thomas' Hospital Campus, London, UK.
Medical Hypotheses
|June 11, 1999
Summary
Azelaic acid, a non-toxic compound, demonstrates significant anti-cancer effects by inhibiting tumor cell growth and DNA synthesis. Its potential as a general antitumoural agent warrants further clinical investigation for various cancers.
Area of Science:
- Oncology
- Biochemistry
Background:
- Azelaic acid is a naturally occurring dicarboxylic acid.
- It exhibits antiproliferative and cytotoxic effects on tumor cell lines.
- Normal cells remain unaffected at therapeutic dosages.
Purpose of the Study:
- To evaluate the antitumoural potential of azelaic acid.
- To explore its efficacy against various cancer types, including melanoma.
Main Methods:
- Inhibition of mitochondrial oxidoreductases and DNA synthesis enzymes.
- Xenotransplantation of human melanoma cells in nude mice.
- Clinical studies on melanoma regression.
Main Results:
- Azelaic acid demonstrated significant effects on xenotransplanted melanoma cells.
- Clinical trials showed regression of in situ and invasive malignant melanoma.
- The compound is well-tolerated across multiple administration routes.
Conclusions:
- Azelaic acid shows promise as a general antitumoural agent.
- Further clinical trials are recommended for melanoma, squamous cell carcinoma, bladder, breast cancers, and leukemia.
- It can be used as prime, adjuvant, or palliative therapy.